Published: 2018-11-23

Articles

NEW DRUG APPROVAL TIMES AND SAFETY WARNINGS IN THE UNITED STATES AND CANADA, 1992-2011

Nigel SB Rawson
Abstract 293 | PDF Downloads 121
PDF

PHARMACOGENOMIC INVESTIGATION OF ADVERSE DRUG REACTIONS (ADRS): THE ADR PRIORITIZATION TOOL, APT

Kaitlyn Shaw, Ursula Amstutz, Lucila Castro-Pastrana, Tenneille T Loo, Colin J Ross, Shinya Ito, Michael J Rieder, Maurica Maher, Stuart MacLeod, Gideon Koren, Michael R Hayden, Bruce C Carleton
Abstract 530 | PDF Downloads 108
PDF

SILDENAFIL AND FUROSEMIDE ASSOCIATED OTOTOXICITY: CONSIDERATION OF DRUG-DRUG INTERACTIONS, SYNERGY, AND BROADER CLINICAL RELEVANCE

Leslie Skeith, Cory Yamashita, Sanjay Mehta, Donald Farquhar, Richard B Kim
Abstract 1223 | PDF Downloads 684
PDF

N-ACETYLCYSTEINE RESCUE PROTOCOL FOR NEPHROTOXICITY IN CHILDREN CAUSED BY IFOSFAMIDE

Lauren Hanly, Michael J Rieder, Shih-Han S Huang, Tetyana L Vasylyeva, Rikin K Shah, Osvaldo Regueira, Gideon Koren
Abstract 787 | PDF Downloads 221
PDF

ECONOMIC BURDEN OF NAUSEA AND VOMITING OF PREGNANCY IN THE USA

Charles Piwko, Gideon Koren, Vusal Babashov, Colin Vicente, Thomas R Einarson
Abstract 1174 | PDF Downloads 336
PDF

THE RETURN TO THE USA OF THE DOXYLAMINE-PYRIDOXINE DELAYED RELEASE COMBINATION (DICLEGIS®) FOR MORNING SICKNESS - A NEW MORNING FOR AMERICAN WOMEN

Gideon Koren
Abstract 554 | PDF Downloads 159
PDF

PREVALENCE OF NAUSEA AND VOMITING OF PREGNANCY IN THE USA: A META-ANALYSIS

Thomas R Einarson, Charles Piwko, Gideon Koren
Abstract 1409 | PDF Downloads 372
PDF

QUANTIFYING THE GLOBAL RATES OF NAUSEA AND VOMITING OF PREGNANCY: A META-ANALYSIS

Thomas R Einarson, Charles Piwko, Gideon Koren
Abstract 3295 | PDF Downloads 987
PDF

THE MANAGEMENT OF NAUSEA AND VOMITING OF PREGNANCY AND HYPEREMESIS GRAVIDARUM- A 2013 UPDATE

Caroline Maltepe, Gideon Koren
Abstract 2413 | PDF Downloads 1037
PDF

USE OF SURROGATE OUTCOMES IN MEDICAL JOURNAL ADVERTISING IN CANADA

Joel Lexchin
Abstract 182 | PDF Downloads 76
PDF

KiDrug Alert Journal Club - Critical Review of "Efficacy of immunoglobin plus prednisone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): A randomized, open-label, blinded-endpoints trial"

Yousef Etoom, Rudaina Banihani, Yaron Finkelstein
Abstract 143 | PDF Downloads 102
PDF

TRANSCENDENTAL PHENOMENOLOGY AND CLASSIC GROUNDED THEORY AS MIXED DATA COLLECTION METHODS IN A STUDY EXPLORING FETAL ALCOHOL SPECTRUM DISORDER IN NEW ZEALAND

Jenny Salmon, Stephen Buetow
Abstract 517 | PDF Downloads 205
PDF

USE OF HEALTH, EDUCATION, AND SOCIAL SERVICES BY INDIVIDUALS WITH FETAL ALCOHOL SPECTRUM DISORDER

Marni D Brownell, Ana C de B. Hanlon-Dearman, Leonard R MacWilliam, Albert E Chudley, Noralou P Roos, Lauren P Yallop, Sally E A Longstaffe
Abstract 493 | PDF Downloads 234
PDF

IS MILD-MODERATE DRINKING IN PREGNANCY HARMLESS? NEW EXPERIMENTAL EVIDENCE TO THE OPPOSITE

Justin Chan, Gideon Koren
Abstract 390 | PDF Downloads 95
PDF

POTENTIAL IMPACTS OF THE ALBERTA FETAL ALCOHOL SPECTRUM DISORDER SERVICE NETWORKS ON SECONDARY DISABILITIES: A COST-BENEFIT ANALYSIS

Nguyen Xuan Thanh, Jessica Moffatt, Philip Jacobs, Anderson W Chuck, Egon Jonsson
Abstract 295 | PDF Downloads 143
PDF

ALCOHOL CONSUMPTION AMONG WOMEN

Irene Zelner, Gideon Koren
Abstract 637 | PDF Downloads 545
PDF